NVAX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

28.05

Margin Of Safety %

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.01

EPS Last/This Y

-3.27

EPS This/Next Y

0.38

Price

7.94

Target Price

13.75

Analyst Recom

2.62

Performance Q

-13.87

Upside

-769.2%

Beta

2.42

Ticker: NVAX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	NVAX	8.91	0.55	0.66	233286
2026-07-14	NVAX	8.43	0.55	0.40	233670
2026-07-15	NVAX	8.42	0.57	0.58	235404
2026-07-16	NVAX	8.24	0.57	0.28	236586
2026-07-17	NVAX	8.22	0.56	0.11	238521
2026-07-20	NVAX	7.88	0.66	0.24	182785
2026-07-21	NVAX	8.07	0.65	0.25	190554
2026-07-22	NVAX	7.91	0.64	0.16	192465
2026-07-23	NVAX	7.82	0.63	0.32	195599
2026-07-24	NVAX	7.45	0.63	0.20	197201
2026-07-27	NVAX	7.5	0.62	0.25	195750
2026-07-28	NVAX	7.36	0.61	0.39	198252
2026-07-29	NVAX	7.33	0.61	0.30	200737
2026-07-30	NVAX	7.45	0.61	0.13	203005
2026-07-31	NVAX	7.32	0.60	0.34	204156
2026-08-03	NVAX	7.41	0.56	0.05	195416
2026-08-04	NVAX	7.66	0.52	0.10	204441
2026-08-05	NVAX	7.71	0.52	0.21	205530
2026-08-06	NVAX	7.74	0.52	0.16	207628
2026-08-07	NVAX	7.93	0.51	0.37	209103
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	NVAX	8.91	-100.0	-	-0.47
2026-07-14	NVAX	8.42	-100.0	-	-0.47
2026-07-15	NVAX	8.43	-100.0	-	-0.47
2026-07-16	NVAX	8.24	-100.0	-	-0.47
2026-07-17	NVAX	8.21	-100.0	-	-0.47
2026-07-20	NVAX	7.88	-100.0	-	-0.47
2026-07-21	NVAX	8.07	-100.0	-	-0.47
2026-07-22	NVAX	7.92	-100.0	-	-0.47
2026-07-23	NVAX	7.83	-100.0	-	-0.47
2026-07-24	NVAX	7.46	-100.0	-	-0.47
2026-07-27	NVAX	7.49	-100.0	-	-0.47
2026-07-28	NVAX	7.36	-100.0	-	-0.47
2026-07-29	NVAX	7.34	-100.0	-	-0.47
2026-07-30	NVAX	7.45	-100.0	-	-0.47
2026-07-31	NVAX	7.31	-100.0	-	-0.47
2026-08-03	NVAX	7.42	-100.0	-	-0.47
2026-08-04	NVAX	7.42	-100.0	-	-0.47
2026-08-05	NVAX	7.71	-100.0	-	-0.47
2026-08-06	NVAX	7.74	-100.0	-	-0.47
2026-08-07	NVAX	7.94	-100.0	-	-0.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	NVAX	0.00	-1.34	29.33
2026-07-14	NVAX	0.00	-1.34	29.33
2026-07-15	NVAX	0.00	-1.34	29.33
2026-07-16	NVAX	0.00	-1.34	29.33
2026-07-17	NVAX	0.00	-1.34	29.33
2026-07-20	NVAX	0.00	-1.34	29.33
2026-07-21	NVAX	0.00	-1.34	29.33
2026-07-22	NVAX	0.00	-1.34	29.33
2026-07-23	NVAX	0.00	-1.34	29.33
2026-07-24	NVAX	0.00	-1.34	29.33
2026-07-27	NVAX	0.00	-1.36	28.06
2026-07-28	NVAX	0.00	-1.36	28.06
2026-07-29	NVAX	0.00	-1.36	28.06
2026-07-30	NVAX	0.00	-1.36	28.06
2026-07-31	NVAX	0.00	-1.36	28.06
2026-08-03	NVAX	0.00	-1.52	28.05
2026-08-04	NVAX	0.00	-1.52	28.05
2026-08-05	NVAX	0.00	-1.52	28.05
2026-08-06	NVAX	0.00	-1.52	28.05
2026-08-07	NVAX	0.00	-1.52	28.05
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.38

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

Institutional Transactions

-1.52

Beta

2.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

100

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.1

Max Drawdown 5-Year %

-98.6

Target Price

13.75

P/E

Forward P/E

PEG

P/S

3.16

P/B

P/Free Cash Flow

EPS

-1.52

Average EPS Est. Cur. Y

-0.55

EPS Next Y. (Est.)

-0.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-59.87

Relative Volume

1.24

Return on Equity vs Sector %

33.4

Return on Equity vs Industry %

49.4

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.08

EBIT Estimation

◆ NVAX Healthcare

$7.95

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

17/25

Volume

4/15

Valuation

12/20

TP/AR

0/10

Options

7/10

RSI

46.7

Range 1M

31.3%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

9/30

Estimates

0/20

Inst/Vol

2/15

Options

7/10

EPS Yr

-124.6%

EPS NY

65.2%

52W%

30.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +73% upside

Quality

7/30

Valuation

14/30

Growth

9/25

Stability

7/10

LT Trend

0/5

Upside

+73%

Quality

NVAX — P/E HistoricalBiotechnology

Novavax, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 749

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX

Latest News

—

Caricamento notizie per NVAX…

stock quote shares NVAX – Novavax, Inc. Stock Price stock today

news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NVAX – Novavax, Inc. yahoo finance google finance

stock history NVAX – Novavax, Inc. invest stock market

stock prices NVAX premarket after hours

ticker NVAX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y